LeonaBio, Inc.
LONA
$11.26
$0.262.36%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/13/2026
-
Insider Monkey
5/11/2026
-
TipRanks Financial Blog
5/7/2026
-
Globe Newswire
5/7/2026
-
Globe Newswire
5/5/2026
-
TipRanks Financial Blog
5/1/2026
-
TipRanks Financial Blog
4/30/2026
-
SeekingAlpha
4/30/2026
-
Seeking Alpha: Transcripts
4/23/2026
-
Globe Newswire
4/21/2026
-
TipRanks Financial Blog
4/21/2026
-
Globe Newswire
4/20/2026
-
TipRanks Financial Blog
4/15/2026
-
MarketBeat
4/8/2026
-
TipRanks Financial Blog
4/6/2026
-
TipRanks Financial Blog
4/6/2026
-
The Fly
4/2/2026
-
TipRanks Financial Blog
3/27/2026
-
SeekingAlpha.com: All News
3/27/2026
-
Seeking Alpha - Healthcare
3/26/2026
-
Globe Newswire
3/19/2026
-
TipRanks Financial Blog
3/6/2026
-
MarketBeat
2/26/2026
-
TipRanks Financial Blog
2/26/2026
-
The Fly
2/26/2026
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 31, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
425 620 8501
Address
18706 North Creek Parkway
Bothell, WA 98011
Bothell, WA 98011
Country
Year Founded
Business Description
Sector
LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and...
more